Diabetes Medications

Ozempic GLP-1 Receptor Agonists Semaglutide GLP-1 Drugs GLP-1 Agonists Counterfeit Drugs Weight Loss Medications Type 2 Diabetes Drugs Jardiance (Boehringer Ingelheim)

6 ARTICLES

3mo ago

FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes Patients

The expanded approval allows Ozempic to reduce risks of kidney failure, cardiovascular death, and disease progression in patients with diabetes and chronic kidney disease.

3 ARTICLES

3mo ago

Fake Ozempic Injections Hospitalize Several in Austria, Raising Counterfeit Drug Concerns Across Europe

Diabetes Medications

FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes Patients

Study Reveals Broad Benefits and Risks of GLP-1 Weight-Loss Drugs

James Corden Reveals Ozempic Failed to Address His Food Addiction

Semaglutide Shows Promise in Reducing Opioid Overdose Risk, Study Finds

Ozempic Shows Promise Beyond Diabetes Treatment

Ozempic Linked to Lower Dementia Risk and Reduced Nicotine Dependence

Eli Lilly Faces Zepbound Shortage, Impacting Weight Loss and Diabetes Patients

Fake Ozempic Injections Hospitalize Several in Austria, Raising Counterfeit Drug Concerns Across Europe